ProfileOfResearchers

TITLE: O018/#482 Updated safety of lenvatinib + pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Bradley Monk; Helen Mackay; Alessandro Santin; David Scott Miller ; Richard Moore; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Kan Yonemori; Yong Man Kim; Eva Guerra Alia; Ulus Sanli; Ran Xie; Melissa Zale; Jodi Mckenzie; Gianmaria Barresi; Domenica Lorusso;
PUBLISHED: 2022, SOURCE: Focused Plenary Abstracts

INDEXED IN:

CrossRef

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: Ovarian Cancer, Version 3.2022 Featured Updates to the NCCN Guidelines. Featured Updates to the NCCN Guidelines
AUTHORS: Deborah K Armstrong; Ronald D Alvarez; Floor J Backes; Jamie N Bakkum Gamez; Lisa Barroilhet; Kian Behbakht; Andrew Berchuck; Lee May Chen; Viola C Chitiyo; Mihaela Cristea; Maria DeRosa; Eric L Eisenhauer; David M Gershenson; Heidi J Gray; Rachel Grisham; Ardeshir Hakam; Angela Jain; Amer Karam; Gottfried E Konecny; Charles A Leath; Gary Leiserowitz; Joyce Liu; Lainie Martin; Daniela Matei; Michael McHale; Karen McLean; David Scott Miller ; Sanja Percac Lima; Steven W Remmenga; John Schorge; Daphne Stewart; Premal H Thaker; Roberto Vargas; Andrea Wahner Hendrickson; Theresa L Werner; Emese Zsiros; Mary A Dwyer; Lisa Hang; ...More
PUBLISHED: 2022, SOURCE: JNCCN Journal of the National Comprehensive Cancer Network, VOLUME: 20, ISSUE: 9

INDEXED IN:

Scopus

CrossRef: 100

IN MY:

ORCID

TITLE: Pembrolizumab in pretreated advanced, metastatic cervical, vulvar, vaginal carcinoma (325) Full Text
AUTHORS: Steven Holloway; David Scott Miller ; Jayanthi Lea;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 166

INDEXED IN:

CrossRef: 1

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women with Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
AUTHORS: Larry J Copeland; Mark F Brady; Robert A Burger; William H Rodgers; Helen Q Huang; David Cella; David M O'Malley; Daron G Street; Krishnansu S Tewari; David P Bender; Robert T Morris; William J Lowery; David Scott Miller ; Summer B Dewdney; Nick M Spirtos; Shashikant B Lele; Saketh Guntupalli; Frederick R Ueland; Gretchen E Glaser; Robert S Mannel; Philip J Disaia; ...More
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 35

INDEXED IN:

Scopus

CrossRef: 4

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
AUTHORS: Matthew A Powell; Virginia L Filiaci; Martee L Hensley; Helen Q Huang; Kathleen N Moore; Krishnansu S Tewari; Larry J Copeland; Angeles A Secord; David G Mutch; Alessandro Santin; David P Warshal; Nick M Spirtos; Paul A DiSilvestro; Olga B Ioffe; David Scott Miller ;
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 9

INDEXED IN:

Scopus

CrossRef: 35

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: Risk factors associated with 30-day postoperative complications following contemporary vulvectomies with inguinofemoral lymphadenectomies for gynecologic cancers Full Text
AUTHORS: Alexandra Spirtos; Salvatore Lococo; Matthew Carlson; Jayanthi Lea; David Scott Miller ; Jessica Lee;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 164, ISSUE: 1

INDEXED IN:

CrossRef

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: 145 Characterization of adverse reactions in patients with advanced endometrial cancer (aec) receiving lenvatinib + pembrolizumab (Study 309/KEYNOTE-775)
AUTHORS: Colombo, N; Lorusso, D; AD Santin; YM Kim; AC Herráez; Yonemori, K; Fujiwara, K; Colomba, E; David Scott Miller ; Pignata, S; BJ Monk; EM Guerra; Kristeleit, R; Orlando, M; UA Sanli; Dutta, L; Orlowski, R; Ren, M; Makker, V;
PUBLISHED: 2021, SOURCE: Endometrial cancer

INDEXED IN:

CrossRef: 2

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: 726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)
AUTHORS: Colombo, N; Lorusso, D; Casado C Herráez; A.D Santin; Colomba, E; David Scott Miller ; Fujiwara, K; Pignata, S; Floquet, A; B.J Monk; Banerjee, S; R.T Penson; Kristeleit, R; Fabbro, M; Orlando, M; Mackay, H; Jensen, E; Dutta, L; Orlowski, R; Makker, V;
PUBLISHED: 2021, SOURCE: Annals of Oncology, VOLUME: 32

INDEXED IN:

CrossRef: 17

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer Full Text
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado Herráez; Alessandro Santin; Emeline Colomba; David Scott Miller ; Keiichi Fujiwara; Sandro Pignata; Sally Baron-Hay; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Kimio Ushijima; Jun Sakata; Kan Yonemori; Yong Man Kim; Eva Guerra; Ulus Sanli; Mary McCormack; Jie Huang; Alan Smith; Stephen Keefe; Lea Dutta; Robert Orlowski; Domenica Lorusso; ...More
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162

INDEXED IN:

CrossRef: 27

IN MY:

ORCID |

CIÊNCIAVITAE

TITLE: Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis Full Text
AUTHORS: Kimberly Levinson; Anna L Beavis; Christopher Purdy; Anne F Rositch; Akila Viswanathan; Aaron H Wolfson; Michael G Kelly; Krishnansu S Tewari; Leah McNally; Saketh R Guntupalli; Omar Ragab; Yi Chun Lee; David Scott Miller ; Warner K Huh; Kelly J Wilkinson; Nicola M Spirtos; Linda Van Le; Yovanni Casablanca; Laura L Holman; Steven E Waggoner; Amanda N Fader; ...More
PUBLISHED: 2021, SOURCE: Gynecologic Oncology, VOLUME: 162, ISSUE: 3

INDEXED IN:

Scopus

CrossRef: 21

IN MY:

ORCID |

CIÊNCIAVITAE